REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables)

3 Months Ended

Mar. 31, 2020

REVENUE RECOGNITION AND RELATED ALLOWANCES

Schedule of disaggregation of revenue and revenue recognized

The following table depicts the disaggregation of revenue according to contract type:

	Three Months Ended
Products and Services	March 31,		March 31,
(in thousands)	2020		2019
Sales of generic pharmaceutical products	$	37,495	$	31,599
Sales of branded pharmaceutical products		9,157		17,543
Sales of contract manufactured products		1,974		2,437
Royalties from licensing agreements		290		577
Product development services		577		320
Other(1)		281		411
Total net revenues	$	49,774	$	52,887

(1)Primarily includes laboratory services and royalties on sales of contract manufactured products.

The following table depicts revenue recognized during the following periods:

	Three Months Ended
Timing of Revenue Recognition	March 31,		March 31,
(in thousands)	2020		2019
Performance obligations transferred at a point in time	$	49,197	$	52,567
Performance obligations transferred over time		577		320
Total	$	49,774	$	52,887

Schedule of accruals and allowances

The following table summarizes activity in the consolidated balance sheets for accruals and allowances for the three months ended March 31, 2020 and 2019, respectively:

	Accruals for Chargebacks, Rebates, Returns, and Other Allowances
							Administrative		Prompt
			Government				Fees and Other		Payment
(in thousands)	Chargebacks		Rebates		Returns		Rebates		Discounts
Balance at December 31, 2018	$	39,007	$	8,974	$	12,552	$	7,353	$	2,009
Accruals/Adjustments		55,831		2,381		3,620		8,207		2,433
Credits Taken Against Reserve		(54,614)		(2,803)		(2,613)		(8,272)		(2,333)
Balance at March 31, 2019	$	40,224	$	8,552	$	13,559	$	7,288	$	2,109
Balance at December 31, 2019	$	49,882	$	8,901	$	16,595	$	8,281	$	2,549
Accruals/Adjustments		95,393		3,567		5,937		8,922		3,361
Credits Taken Against Reserve		(51,575)		(4,438)		(4,918)		(8,817)		(2,219)
Balance at March 31, 2020	$	93,700	$	8,030	$	17,614	$	8,386	$	3,691